Wang Y, Wang Y, Mu Y, Cheng Y, et al. Effects of SGLT2 inhibitors on development and progression of kidney disease in
Chinese patients with type 2 diabetes: A multicentre, prospective real-world
study. Diabetes Obes Metab 2025 Dec 28. doi: 10.1111/dom.70413.
PMID: 41457330
|